Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Austin, USA
7000 North Mopac Expwy.
2nd Floor
Austin, TX, 78731
USA

People

Chief Executive Officer
CFO
Director
Chief Medical Officer

Funding

TOTAL $33M
FUNDING TOTAL $33M
Partial Close, 5/2010
$18M
Venture Round, 8/2011
SV Life Sciences
Genesis Capital
Forward Ventures
$15M
DEBT TOTAL $30.8M
Debt, 8/2011
$18.9M
Debt, 9/2013
Forward Ventures
SV Life Sciences
Oxford Bioscience Partners
$11.9M

Tags

Affinium Pharmaceuticals

Affinium Pharmaceuticals is a specialty pharmaceutical company focused on the development of novel anti-infective medicines. The Affinium FASII antibacterial programs constitute a new antibiotic franchise with the potential for multiple products targeting the FASII pathway. These programs include a broad base of long-term intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors for a new class of antibiotics with a unique mechanism of action, targeting an underexploited pathway.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. Affinium Pharmaceuticals Announces the Closing of $15 Million Financing (afnm.com) [edit]
  4. Affinium Pharmaceuticals raises $12 million in debt financing (canadianprivateequity.com) [edit]
Edit This Page
Last Edited 12/24/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy